Center For Cancer Research Funding, Inc New Haven, CT - 06513

Center For Cancer Research Funding, Inc is categorized under Self Help Groups in New Haven, CT and active since 2008.

Center For Cancer Research Funding, Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Self Help Groups business, which does work in the B2C market, and is classified as a Self Help Groups, under code number by the NAICS.

If you are seeking more information, feel free to contact Michael Galbraith at the company’s headquarters by writing to 105 Paul Street, New Haven, Connecticut CT 06513 or by phoning (203) 672-1325. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Center For Cancer Research Funding, Inc
Contact Person: Michael Galbraith
Address: 105 Paul Street, New Haven, Connecticut 06513
Phone Number: (203) 672-1325
Website Address: ccrfct.org
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Self Help Groups
Share This Business:

Center For Cancer Research Funding, Inc was started in 2008 to provide professional Self Help Groups under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Michael Galbraith for inquiries that concern Center For Cancer Research Funding, Inc by calling the company number (203) 672-1325, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Center For Cancer Research Funding, Inc can be found at the coordinates 41.32279,-72.86519 as well as the street address 105 Paul Street in New Haven, Connecticut 06513.

For its online presence, you may visit Center For Cancer Research Funding, Inc’s website at ccrfct.org and engage with its social media outlets through on Twitter and on Facebook.